Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David H Margolin
Impact of Alemtuzumab on Health-Related Quality of Life Over 6 Years in CARE-MS II Trial Extension Patients With Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
Neurology
Related publications
Acute Effects of Alemtuzumab Infusion in Patients With Active Relapsing-Remitting MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Change in the Health-Related Quality of Life of Multiple Sclerosis Patients Over 5 Years
International Journal of MS Care
Neurology
Specialized Nursing
Advanced
Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
The Impact of Pain and Other Symptoms on Quality of Life in Women With Relapsing-Remitting Multiple Sclerosis
Journal of Neuroscience Nursing
Endocrine
Medical
Autonomic Systems
Surgical Nursing
Neurology
Surgery
Long-Term Safety and Efficacy of Natalizumab in Relapsing-Remitting Multiple Sclerosis: Impact on Quality of Life
Patient Related Outcome Measures
Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis
Arquivos de Neuro-Psiquiatria
Biological Psychiatry
Neurology
Health State Utilities in Patients With Relapsing Remitting Multiple Sclerosis Treated With Cladribine Tablets
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Alemtuzumab: A Review of Efficacy and Risks in the Treatment of Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management
Comparing the Quality of Life Among Patients With Relapsing Remitting Multiple Sclerosis in Iraq Using Different Disease Modifying Therapies
Iraqi Journal of Pharmaceutical Sciences
Toxicology
Analytical Chemistry
Pharmaceutics
Pharmacology
